Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05253131
Title Trial of Selumetinib and AZD5153 With Durvalumab for Sarcomas
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
The University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
Children's Hospital Los Angeles Los Angeles California 90027 United States Details
Children's National Medical Center Washington District of Columbia 20010 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Indiana University Indianapolis Indiana 46202 United States Details
Johns Hopkins University Baltimore Maryland 21287 United States Details
National Cancer Institute (NCI) Bethesda Maryland 20892 United States Details
Mayo Clinic Minneapolis Minnesota 56001 United States Details
Washington University - St. Louis Saint Louis Missouri 63110 United States Details
New York University Medical Center New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229-3039 United States Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19096 United States Details
Childrens Medical Center - Univ. of Texas SW Dallas Texas 75235 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field